Serum visfatin in nonalcoholic fatty liver disease

Autores: Polyzos Stergios A, Kountouras Jannis, Romiopoulos Iordanis, Polymerou Vaia

Fragmento

Dear Editor: We read with interest the study of Genc, et al. showing similar plasma visfatin levels between men with nonalcoholic fatty liver disease (NAFLD) and healthy controls of lower body mass index (BMI) and waist circumference (WC). Furthermore, visfatin was similar in different grades of steatosis, ballooning and lobular inflammation or stages of fibrosis. Interestingly, visfatin was negatively correlated with tumor necrosis factor (TNF)-α, but not with interleukin (IL)-6, high-sensitivity C-reactive protein (hsCRP) or adiponectin.

Palabras clave:

2014-03-01   |   217 visitas   |   Evalua este artículo 0 valoraciones

Vol. 13 Núm.1. Enero-Febrero 2014 Pags. 150-151 Ann Hepatol 2014; 13(1)